J. E. Wraith - Concepedia

Author

J. E. Wraith

Also Known As

J E Wraith, J Ed Wraith, J. E. WRAITH, J. E. Wraith, J. Ed Wraith, J.E. Wraith, J.Ed. Wraith, JAMES WRAITH, James E Wraith, James E. Wraith

Publications

7.6K

Citations

H-Index

143

Concepts

All Affiliations

Royal Manchester Children's Hospital Boston Children's Hospital University of Manchester St. Mary's Hospital Royal Children's Hospital

About

J. E. Wraith is an author at Royal Manchester Children's Hospital specializing in medicine, pathology, and lysosomal storage disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	33	3.1K
2	Health Sciences	4	4	211
3	Public Health	3	3	317
4	Natural Sciences	2	2	362
5	Engineering	1	1	16

J. E. Wraith

Publications

7.2K

Citations

H-Index

Page 1

	Year	Citations
A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow Robert Wynn, Claire A. Hart, Carla Corradi-Perini, Blood	2004	771
Study of Telomere Length Reveals Rapid Aging of Human Marrow Stromal Cells following In Vitro Expansion M. Baxter, Robert Wynn, Simon N. Jowitt, Stem Cells	2004	769
Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study Marc C. Patterson, Darleen Vecchio, Helena Prady, The Lancet Neurology MedicineNiemann-pick C DiseasePathology	2007	599
Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-L-iduronidase (laronidase) J. E. Wraith, L. Clarke, Michael Beck, The Journal of Pediatrics Enzyme Replacement TherapyRecombinant Human α-L-iduronidasePathologyNeurologyMultinational Study	2004	540
Mucopolysaccharidosis I: Management and Treatment Guidelines Joseph Muenzer, J. E. Wraith, L. Clarke PEDIATRICS	2008	451
Refsum disease is caused by mutations in the phytanoyl–CoA hydroxylase gene Gerbert A. Jansen, Rob Oftnan, Sacha Ferdinandusse, Nature Genetics BiologyGenetic DisorderNatural SciencesGeneticsRefsum Disease	1997	304
Miglustat in patients with Niemann-Pick disease Type C (NP-C): A multicenter observational retrospective cohort study M. Pineda, J. E. Wraith, Eugen Mengel, Molecular Genetics and Metabolism Clinical EpidemiologyClinical DiseasePublic HealthDisease AssessmentMedicine	2009	192
Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB Fiona L. Wilkinson, Rebecca Holley, Kia Langford‐Smith, PLoS ONE	2012	177
Long-Term Miglustat Therapy in Children With Niemann-Pick Disease Type C Marc C. Patterson, Darleen Vecchio, Elizabeth Jacklin, Journal of Child Neurology	2009	167
Long‐term follow‐up following bone marrow transplantation for Hunter disease Ashok Vellodi, E. Young, Alan Cooper, Journal of Inherited Metabolic Disease	1999	166

Page 1